In this article, we will analyze the list of the best blue chip dividend stocks.
When it comes to investing in stocks, investors often keep a close eye on the company’s financial health. Why? Because it directly impacts the potential returns on their investments. This is especially crucial for income investors, as solid financial health ensures regular dividend payments and steady dividend growth. In short, a company’s strong financial footing means it’s more likely to keep the cash flowing and the dividends climbing. Blue chip companies, especially those with over $100 billion in market cap, take the lead in this area. These firms are well-established, financially stable, and top players in their industries.
The Dow Jones Industrial Average is commonly regarded as an index of blue chip stocks. This widely watched stock market index includes 30 of the largest and most established publicly traded companies in the US. The index surged by over 4.7% since the start of 2024 and in the past 12 months, it gained 16.4%.
When comparing the performance of the broader market and the Dow Jones, both of which track large-cap U.S. companies, historical data reveals a high correlation between the two indices over time. However, there have been notable instances where their performances diverged significantly. According to a report from S&P Dow Jones Indices, the market substantially outperformed the Dow Jones over one- and three-year periods. Conversely, over the 30-year period leading up to 2019, the Dow Jones slightly outperformed the broader market. This indicates that although these indices often move together, short-term performance can vary, and specific market conditions and economic factors can influence which index performs better during different periods. The Dow Jones underperformed the broader market in 2023 by a wide margin.
While analysts frequently compare the performance of these two indices, it is important to note that the Dow represents only a small segment of the economy. In contrast, the broader market includes nearly 17 times as many companies. According to estimates from S&P Dow Jones Indices, more than $11.2 trillion investments were benchmarked to the broader market at the end of 2019. This is a staggering 350 times greater than the $32 billion benchmarked to the Dow. A key reason for the broader market’s outperformance compared to the Dow last year is that the market places more emphasis on the tech giants, which were the primary drivers of the wider market’s gains throughout the year.
Returning to the importance of blue chip companies, investors favor these firms because their strong financial health allows them to grow their dividends consistently. Dividend growth has remained a strong preference of investors over the years, prompting companies to increase their dividend payouts steadily. In this article, we will take a look at some of the best blue-chip dividend stocks.
photo by scott graham on Unsplash
Our Methodology:
For this list, we began by examining the current members of the Dow 30 that boasted a minimum market capitalization of $100 billion as of July 7. From this initial group, we specifically focused on companies that consistently pay dividends to their shareholders and have yields of at least 2%, as of July 7. These stocks were then ranked in ascending order of the number of hedge funds having stakes in them at the end of Q1 2024, as per Insider Monkey’s database. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).
10. International Business Machines Corporation (NYSE:IBM)
Number of Hedge Fund Holders: 49
International Business Machines Corporation (NYSE:IBM) is an American technology company that specializes in a wide range of related services, including consulting, technology, cloud computing, artificial intelligence, and data analytics. The company is currently the sole provider offering both a comprehensive technology stack through their Watsonx platform and consulting services for deploying and managing generative AI. The stock has been declining over the past decade but has recently gained momentum because of its potential in the field of AI. Since the start of 2024, the stock has gained nearly 9% and its 12-month returns came in at over 33%.
Over the years, International Business Machines Corporation (NYSE:IBM) has transformed itself into a blend of hardware, software, and consulting solutions, though it has faced challenges in maintaining consistent growth. The company is optimistic that AI will drive future revenue growth. In the first quarter of 2024, its Watsonx and generative AI business has shown strong, consistent momentum, growing each quarter, and has surpassed $1 billion in revenues since the launch of Watsonx in mid-2023. For the full year, the company continues to anticipate revenue performance consistent with its mid-single-digit growth model and approximately $12 billion in free cash flow.
Diamond Hill Capital highlighted International Business Machines Corporation (NYSE:IBM)’s AI business in its Q1 2024 investor letter. Here is what the firm has to say:
“Among our bottom Q1 contributors short positions in Dick’s Sporting Goods, International Business Machines Corporation (NYSE:IBM) and Palomar Holdings. Though we believe the quality and durability of IBM’s free cash flow-generating capabilities remain questionable, investor sentiment has improved amid optimism for the company’s still-nascent AI product suite.”
On April 30, International Business Machines Corporation (NYSE:IBM) declared a 0.6% hike in its quarterly dividend to $1.67 per share. This was the company’s 29th consecutive year of dividend growth, which makes IBM one of the best blue chip dividend stocks on our list. As of July 7, the stock has a dividend yield of 3.80%.
At the end of Q1 2024, 49 hedge funds tracked by Insider Monkey reported having stakes in International Business Machines Corporation (NYSE:IBM), compared with 50 in the previous quarter. The consolidated value of these stakes is over $1 billion. With over 1.2 million shares, AQR Capital Management was the company’s leading stakeholder in Q1.
9. Cisco Systems, Inc. (NASDAQ:CSCO)
Number of Hedge Fund Holders: 58
Cisco Systems, Inc. (NASDAQ:CSCO) is a California-based digital communications technology company that specializes in related services. Recognizing the growth potential of AI trends, the company gradually immersed itself in this revolutionary field. It has collaborated with a range of AI startups to establish a $1 billion global AI investment fund aimed at strengthening the startup ecosystem and developing reliable AI solutions. Over the past few years, the company has broadened its AI portfolio by acquiring or investing in more than 20 AI-focused projects. In addition, Cisco Systems, Inc. (NASDAQ:CSCO) has announced a new partnership with Nvidia to create the Cisco Nexus Hyperfabric AI clusters, designed to simplify the deployment of generative AI applications.
In fiscal Q3 2024, Cisco Systems, Inc. (NASDAQ:CSCO) reported revenue of $12.7 billion, which fell by 13% from the same period last year, however, managed to beat analysts’ expectations by $79 million. The revenue reflected its customers’ ongoing adoption of its available products. The company’s subscription revenue came in at $6.9 billion, which represented 54% of its total revenue for the quarter. Earlier this year, the company enhanced its cyber threat protection capabilities by acquiring data analytics and cybersecurity firm Splunk. The acquisition proved to be beneficial for the company. In the most recent quarter, Splunk contributed $413 million to the company’s revenue. Cisco’s shares are trading a forward P/E ratio of 13.24 times the average Street estimate for 2024 EPS of $3.70, which is considered a bargain within the tech sector.
Cisco Systems, Inc. (NASDAQ:CSCO), one of the best dividend stocks on our stocks, has been growing its payouts for 17 consecutive years. It currently offers a quarterly dividend of $0.40 per share and has a dividend yield of 3.43%, as of July 7. In Q3 2024, the company returned nearly $3 billion to shareholders through dividends and share buybacks.
As of the end of Q1 2024, 58 hedge funds in Insider Monkey’s database reported having stakes in Cisco Systems, Inc. (NASDAQ:CSCO), down slightly from 60 in the preceding quarter. These stakes are collectively valued at more than $1.6 billion.
8. The Coca-Cola Company (NYSE:KO)
Number of Hedge Fund Holders: 62
An American multinational beverage company, The Coca-Cola Company (NYSE:KO) ranks eighth on our list of the best dividend stocks. On May 2, the company declared a quarterly dividend of $0.485 per share, which was in line with its previous dividend. Overall, it holds a 62-year streak of consistent dividend growth. The stock supports an impressive dividend yield of 3.04%, as of July 7.
Regardless of how successful or unique a company may be, maintaining a balanced portfolio often requires strategic acquisitions. The Coca-Cola Company (NYSE:KO), recognizing shifting consumer preferences away from sugary sodas, has been heavily investing in diversifying its product offerings. Over the past decade, through several acquisitions, the company managed to boost its revenue, which had been somewhat declining significantly. The company grew its net sales from $33 billion in 2020 to $46 billion in 2023. In the first quarter of 2024, it reported revenue of $11.2 billion, which showed a 3% growth from the same period last year.
For income investors, cash flow is the bedrock of any company. The health of cash flow determines whether the company can continue to pay or uphold its dividends. In the most recent quarter, The Coca-Cola Company (NYSE:KO) reported strong cash position. Its operating cash flow came in at $528 million, showing an increase of $368 million from the prior year period. The company’s free cash flow also showed an increase of $274 million at $158 million. It expects a strong cash position for the year ahead, projecting to distribute around $84 billion in dividends for 2024, supported by an estimated $9.2 billion in free cash flow. However, after accounting for these cash outflows, there isn’t much remaining for the company to use towards reducing its $43.7 billion in total debt. In addition, its debt-to-equity ratio of 1.56 is considered somewhat elevated.
The Coca-Cola Company (NYSE:KO) was a part of 62 hedge fund portfolios at the end of Q1 2024, which remained the same as in the previous quarter, according to Insider Monkey’s database. The stakes held by these hedge funds have a collective value of over $28.5 billion. Among these hedge funds, Berkshire Hathaway owned 400 million KO shares, becoming the company’s leading stakeholder.
7. McDonald’s Corporation (NYSE:MCD)
Number of Hedge Fund Holders: 63
McDonald’s Corporation (NYSE:MCD) is an Illinois-based fast-food restaurant company. It posted strong earnings in the first quarter of 2024, reporting revenue of $6.17 billion, showing a 4.60% growth from the same period last year. The company has achieved positive comparable sales growth for 13 consecutive quarters, with a notable 30% increase over the past four years. Global comparable sales rose by 2% in the most recent quarter, driven by positive comparable sales in both the US and International Operated Market Segments.
Earlier this year, McDonald’s Corporation (NYSE:MCD) stock reached its highest-ever trading level at around $300 per share. However, concerns among investors about broader macroeconomic factors, inflation, and geopolitical tensions, have emerged as potential risks, signaling potential challenges ahead for the company’s performance. However, the company has consistently surprised its investors over the years. Despite encountering various challenges in the past, it has consistently rebounded and strengthened its operations. Not to forget the Great Financial Crisis of 2007, during which the stock delivered nearly a 36% return between July 2007 and July 2010.
These short-term headwinds were also noted by Carillon Tower Advisers in its Q1 2024 investor letter. Here is what the firm has to say about MCD:
“McDonald’s Corporation (NYSE:MCD) faces several short-term headwinds. Lower-income consumers have been cautious with spending, as they are feeling the cumulative effects of inflation more than higher-income cohorts. As the low cost/ value player in fast food, McDonald’s has a customer base that skews lower income. Also, as an international company, McDonald’s is feeling negative effects from war and tensions in the Middle East, as well as softness in China.”
McDonald’s Corporation (NYSE:MCD) intends to maintain its expansion trajectory, aiming to reach 50,000 restaurants by 2027, up from its current count of over 40,000 locations.
McDonald’s Corporation (NYSE:MCD) currently offers a quarterly dividend of $1.67 per share for a dividend yield of 2.66%, as of July 7. It is one of the best dividend stocks on our list as the company has been growing its payouts for 47 consecutive years. The company remained committed to its shareholder returns over the years. In 2023, it returned $7.6 billion to investors through dividends and share repurchases.
Insider Monkey’s database of Q1 2024 indicated that 63 hedge funds held stakes in McDonald’s Corporation (NYSE:MCD), the same as in the previous quarter. These stakes have a total value of nearly $2.3 billion.
6. Amgen Inc. (NASDAQ:AMGN)
Number of Hedge Fund Holders: 63
Amgen Inc. (NASDAQ:AMGN) is an American biotech company that mainly deals in the manufacturing of innovative therapies. The company’s investors have much to look forward to with MariTide, a weight loss drug that has the potential to be a major competitor to products from Novo Nordisk and Eli Lilly. In its recent earnings release, the company announced that topline Phase 2 data for this drug is expected by late 2024. It also stated that it plans to conduct Phase 3 trials for MeriTide across multiple indications. If brought to market, this drug could significantly boost the company’s revenue by billions and serve as a major catalyst for both its overall sales and share price.
In recent years, Amgen Inc. (NASDAQ:AMGN) has been growing its business through acquisitions in an effort to boost its revenue and achieve much-needed growth. One of its acquisitions, Horizon Therapeutics, which was closed in October last year, generated $914 million in sales in the first quarter of 2024. Overall, the company reported revenue of over $7.4 billion, which showed a significant hike of 22% from the same period last year. In the past year, the stock is up by over 42%, outperforming the broader market, which returned 26.5% during this period.
Amgen Inc. (NASDAQ:AMGN) is one of the best dividend stocks on our list as the company has been rewarding shareholders with growing dividends for the past 11 years. The stock also has an impressive dividend yield of 2.90%, as recorded on July 7. However, the company’s trailing twelve-month payout ratio of 123.2% doesn’t sit well with dividend investors. This was also seen in the most recent quarter when it paid more in dividends than it generated. The company’s operating cash flow for the quarter came in at $0.7 billion and its free cash flow for the period stood at $0.5 billion. It returned $1.2 billion to shareholders through dividends. That said, biotech companies prioritize reinvesting their profits in research and development (R&D) over paying dividends. Therefore, the high payout ratio shouldn’t be a major concern for investors.
According to Insider Monkey’s database of Q1 2024, 63 hedge funds owned investments in Amgen Inc. (NASDAQ:AMGN), compared with 69 in the previous quarter. These stakes have a consolidated value of over $1.3 billion.
5. Verizon Communications Inc. (NYSE:VZ)
Number of Hedge Fund Holders: 67
Verizon Communications Inc. (NYSE:VZ) is a New York-based telecommunications company that provides services related to technology, communications, information, and entertainment. On June 5, the company declared a quarterly dividend of $0.665 per share, which fell in line with its previous dividend. Overall, it has been growing its dividends for 17 consecutive years, which makes VZ one of the best dividend stocks on our list. As of July 7, the stock has a dividend yield of 6.45%.
Recently, Goldman Sachs initiated its coverage of Verizon Communications Inc. (NYSE:VZ) and maintained a Buy rating on the stock as a part of its broader coverage initiation on the US Telecom Services and Infrastructure sector. According to the firm, the U.S. telecom industry is undergoing a transformation, with operators now concentrating on their core businesses after a period of operating as conglomerates that led to shareholder capital losses. The firm believes that the company will achieve steady growth in revenue, EBITDA, and free cash flow over the next 18 months. The signs of this growth can already be seen in the company’s Q1 2024 earnings. It generated revenue of roughly $33 billion, which showed a slight increase of 0.21% from the same period last year. Moreover, its cash flow for the quarter also jumped from $2.3 billion to $2.7 billion.
In the most recent quarter, Verizon Communications Inc. (NYSE:VZ) also showed strength in its core wireless business. Total wireless revenues grew by 3.3% YoY to $19.5 billion and fixed wireless revenue also showed an increase of $197 million from the prior year period to $452 million. The company’s fixed wireless subscriber base is also growing quickly, and its network is widely regarded as the best in the industry. According to analysts, the company is all set to achieve a net increase in phone subscribers over the next two years.
One drawback to Verizon’s otherwise strong balance sheet is its significant debt load. Verizon Communications Inc. (NYSE:VZ) has amassed over $180 billion in total debt. With a payout ratio of 60%, the company allocates over half of its earnings to dividends, leaving limited funds available for debt repayment. Additionally, Verizon’s forward P/E ratio of 8.97 indicates that the stock is trading at nearly nine times its expected future earnings, suggesting the market has concerns about its financial flexibility given the high debt levels.
The number of hedge funds tracked by Insider Monkey owning stakes in Verizon Communications Inc. (NYSE:VZ) grew to 67 in Q1 2024, from 63 in the previous quarter. These stakes are collectively valued at over $2.1 billion. With nearly 9 million shares, Citadel Investment Group was the company’s leading stakeholder in Q1.
4. The Procter & Gamble Company (NYSE:PG)
Number of Hedge Fund Holders: 69
An American multinational consumer goods company, The Procter & Gamble Company (NYSE:PG) ranks fourth on our list of the best dividend stocks. The company targets the high end of the market with its products, striving to justify this premium positioning through extensive research and development, ensuring its products provide real, tangible benefits. It spends nearly $2 billion on R&D annually, which is about 50% more than its nearest competitor and exceeds the combined R&D spending of most other competitors.
The Procter & Gamble Company (NYSE:PG) reported stable earnings in fiscal Q3 2024 as three of its divisions, including beauty, grooming, and fabric & home care showed YoY volume growth of 1%, 2%, and 1%, respectively. However, its healthcare and baby, feminine, and family care divisions experienced further volume declines. The company attributed these decreases to higher prices and a milder cold and flu season. Geography also impacted its sales, with China, The Procter & Gamble Company’s (NYSE:PG) second-largest market, still experiencing weak demand for products. In addition, the company’s CEO noted that in some regions, particularly the Middle East, retailers have reduced promotions due to ongoing geopolitical tensions.
The Procter & Gamble Company (NYSE:PG) offers a quarterly dividend of $1.0065 per share, having raised it by 7% in April this year. Through this increase, the company stretched its dividend growth streak to 68 years, which makes it one of the best blue chip dividend stocks on our list. Moreover, it has been paying regular dividends to shareholders for the past 134 years. The company’s cash position is strong, which shows that it can continue with its dividend policy by achieving its targets. In the most recent quarter, the company generated over $4 billion in operating cash flow and its adjusted free cash flow came in at $3.3 billion with a free cash flow productivity of 87%. The company maintains its forecast for adjusted free cash flow productivity at 90%. It also plans to pay over $9 billion in dividends in 2024. The stock has a dividend yield of 2.44%, as of July 7.
After more than two years, The Procter & Gamble Company (NYSE:PG) reached a new all-time high of $168 per share in June this year, surpassing its previous peak of around $165. This achievement is largely due to the company’s strong execution. The company has consistently performed well, particularly during inflationary periods when it successfully implemented substantial price increases. For instance, in fiscal 2023, the company saw organic sales growth in every quarter.
As per Insider Monkey’s database of Q1 2024, 69 hedge funds owned stakes in The Procter & Gamble Company (NYSE:PG), down slightly from 71 in the previous quarter. These stakes have a total value of over $7.2 billion.
3. Johnson & Johnson (NYSE:JNJ)
Number of Hedge Fund Holders: 80
Johnson & Johnson (NYSE:JNJ) is an American pharmaceutical industry company that also specializes in healthcare consumer products. The company has been under significant pressure due to numerous talc lawsuits involving tens of thousands of people who claim that the company’s talc products, such as baby powder contain asbestos and can cause ovarian cancer. If the company can successfully resolve this issue, it would remove what is arguably the biggest risk and uncertainty facing the business today, potentially providing a boost to the stock. Since the start of 2024, the stock has declined by over 8%.
That said, Johnson & Johnson (NYSE:JNJ) is focusing on the next phase of its business, which investors hope will lead to greater growth than in previous years. Last year, the company spun off its consumer health division, and now, with only two main segments—medical devices and innovative medicines—it might be well-positioned to boost its growth rate. In the first quarter of 2024, the company posted revenue of over $21.3 billion, which showed a 2.3% growth from the same period last year. Its international sales saw a decline of 3.4% on a YoY basis. Its innovative medicine segment accounted for $13.5 billion of its total revenue. The company expects a modest increase in its growth rate. Management projects an annual operational growth rate of 5% to 7% from 2025 to 2030. In addition, the company expects to have over 10 assets capable of generating at least $5 billion in peak annual sales.
Johnson & Johnson (NYSE:JNJ) holds one of the longest dividend growth streaks in the market, spanning over 62 years. The company pays a quarterly dividend of $1.24 per share for a dividend yield of 3.39%, as of July 7.
At the end of March 2024, 80 hedge funds in Insider Monkey’s database reported having stakes in Johnson & Johnson (NYSE:JNJ), compared with 81 in the previous quarter. These stakes have a collective value of more than $4.2 billion. With over 6.6 million shares, Fisher Asset Management was the company’s leading stakeholder in Q1.
2. Merck & Co., Inc. (NYSE:MRK)
Number of Hedge Fund Holders: 95
Merck & Co., Inc. (NYSE:MRK) is a New Jersey-based pharmaceutical company that provides innovative health solutions to its consumers. The pharmaceutical industry is currently facing a significant investment challenge. The performance of big pharma stocks over the past two decades has been notably unimpressive. This lackluster performance is primarily attributed to the growing risks inherent in the big pharma business model, which requires substantial investments in ongoing research and development for new drug trials.
What sets Merck & Co., Inc. (NYSE:MRK) apart from its peers is its ongoing success in leveraging acquisitions for continuous benefits over the years. In March this year, the company acquired Harpoon Therapeutics in a deal worth $656 million. This move will strengthen its oncology pipeline directly, and it may also open up opportunities for developing potent new combination therapies in the near future. Since the acquisition, the stock is up by 3% and has gained nearly 12% so far this year. Carillon Tower Advisers highlighted the stock’s strong returns in its Q1 2024 investor letter. Here is what the firm has to say about MRK:
“After posting lackluster returns in 2023, Merck & Co., Inc. (NYSE:MRK) got off to a strong start in January by raising the long-term sales forecasts for its oncology and cardiology pipelines and reporting solid fourth-quarter results, coupled with strong financial guidance for 2024. Merck shares also finished the quarter strong after receiving U.S. Food and Drug Administration approval in late March for a new cardiology medicine with the potential to contribute significantly to sales growth over the next several years.”
In addition to acquisitions, Merck & Co., Inc. (NYSE:MRK) spends a lot on R&D. In the first quarter of 2024, the company’s R&D expenses were $4 billion, down slightly from $4.3 billion in the same period last year. The company’s revenue for the quarter came in at $15.7 billion, up 9% from the prior-year period. The company highlighted in its earnings report that it is leveraging innovation to drive forward its extensive pipeline and is optimizing the effectiveness of its wide-ranging commercial portfolio for the benefit of its patients. The stock is currently trading at a forward P/E multiple of 14.64x, which is lower than the industry’s average of 18.88, indicating potential undervaluation related to its peers.
On May 28, Merck & Co., Inc. (NYSE:MRK) declared a quarterly dividend of $0.77 per share, which was in line with its previous dividend. The company has been rewarding shareholders with 13 consecutive years of dividend hikes. The stock has a dividend yield of 2.44%, as of July 7.
Of the 920 hedge funds tracked by Insider Monkey at the end of Q1 2024, 95 funds owned stakes in Merck & Co., Inc. (NYSE:MRK), compared with 98 in the previous quarter. The consolidated value of these stakes is more than $8 billion.
1. JPMorgan Chase & Co. (NYSE:JPM)
Number of Hedge Fund Holders: 112
JPMorgan Chase & Co. (NYSE:JPM) is an American investment banking company that specializes in a wide range of related services and products. The stock has outperformed the broader market over the past two years, delivering an 80% return to shareholders, while the market returned over 42% during this period. The company is currently experiencing strong business momentum, driving its performance forward. In the first quarter of 2024, it reported revenue of $42 billion, up from $38.3 billion from the same period last year. The company posted a 2% expansion in its deposit base and a 16% increase in loans during the quarter, which analysts see as positive trends. In addition, while the bank increased its provision for credit losses by $1.9 billion, this figure was lower than the $2.3 billion recorded in the same period last year.
JPMorgan Chase & Co. (NYSE:JPM) could see continued positive outcomes once the Federal Reserve begins to decrease interest rates. In comparison to smaller banks, the company benefits from a cost advantage in attracting low-cost deposits and efficiently leveraging its substantial expenses across a larger revenue base. This trend contributes to strong and consistent profitability.
Carillon Tower Advisers highlighted JPMorgan Chase & Co. (NYSE:JPM)’s strong performance in its Q1 2024 investor letter. Here is what the firm has to say:
“JPMorgan Chase & Co. (NYSE:JPM) contributed positively to performance following solid financial results and positive guidance for the remainder of 2024. Moreover, growing chatter around rising capital markets activity likely contributed to the stock’s strong performance relative to other banks. Recall that JPMorgan has a robust capital markets franchise.”
JPMorgan Chase & Co. (NYSE:JPM) pays a quarterly dividend of $1.15 per share and plans to increase it by nearly 9% after completing its stress test process. With a dividend yield of 2.25% as of July 7, JPM is one of the best dividend stocks on our list. In the most recent quarter, it returned $3.3 billion to shareholders through dividends.
JPMorgan Chase & Co. (NYSE:JPM) was a popular buy among elite funds in the first quarter of 2024, as 112 funds held stakes in the company, growing from 103 in the previous quarter, according to Insider Monkey’s database. These stakes have a consolidated value of over $8.4 billion.
While we acknowledge the potential of JPM as an investment, our conviction lies in the belief that some deeply undervalued dividend stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for a deeply undervalued dividend stock that is more promising than JPM but that trades at less than 7 times its earnings and yields nearly 10%, check out our report about the dirt cheap dividend stock.
READ NEXT: Analyst Sees a New $25 Billion “Opportunity” for NVIDIA and 10 Best of Breed Stocks to Buy For The Third Quarter of 2024 According to Bank of America.
Disclosure: None. This article is originally published at Insider Monkey.
